US Broker Ratings

ANI Pharmaceuticals, Inc. (ANIP) Stock Analysis: Exploring a Promising 47% Upside Potential

ANI Pharmaceuticals, Inc. (ANIP), a prominent player in the healthcare sector, operates within the highly competitive drug manufacturing industry, focusing on both specialty and generic pharmaceuticals. With a market capitalization..

Viridian Therapeutics, Inc. (VRDN) Stock Analysis: 49.84% Potential Upside in the Biotech Frontier

Viridian Therapeutics, Inc. (NASDAQ: VRDN) is capturing the attention of investors with its impressive potential upside, as the company embarks on a groundbreaking journey in the biotechnology sector. With a..

Vera Therapeutics, Inc. (VERA) Stock Analysis: Exploring a 78.68% Potential Upside in Biotechnology

Vera Therapeutics, Inc. (NASDAQ: VERA), a burgeoning player in the biotechnology sector, has captured the attention of investors with a notable market cap of $2.99 billion and a promising pipeline..

National HealthCare Corporation (NHC): A Look at Performance Highlights and Market Position in the Healthcare Sector

As an investor, keeping an eye on National HealthCare Corporation (NYSE: NHC) could be a strategic move, especially given its robust presence in the healthcare sector. Based in Murfreesboro, Tennessee,..

Haemonetics Corporation (HAE) Stock Analysis: Exploring a 43.58% Upside Potential

Haemonetics Corporation (NYSE: HAE) is capturing investor attention with its promising potential for a substantial upside. Positioned within the healthcare sector, this Boston-based medical device company specializes in an array..

ACADIA Pharmaceuticals Inc. (ACAD) Stock Analysis: Exploring a 27% Upside Potential and Robust CNS Portfolio

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) stands out in the biotechnology sector with a focus on central nervous system (CNS) disorders and rare diseases. With a current market capitalization of $4.18..

The Pennant Group, Inc. (PNTG): Investor Outlook on a Healthcare Growth Opportunity with a 15% Upside

As investors navigate the healthcare sector, The Pennant Group, Inc. (NASDAQ: PNTG) presents an intriguing opportunity. Headquartered in Eagle, Idaho, this company operates in the medical care facilities industry, providing..

Phreesia, Inc. (PHR) Stock Analysis: A Healthcare SaaS Innovator with a Promising 139.77% Potential Upside

Investors seeking exposure to the dynamic intersection of technology and healthcare might find Phreesia, Inc. (PHR) an intriguing prospect. This Delaware-based company offers a comprehensive SaaS-based platform that revolutionizes patient..

Kestra Medical Technologies, Ltd. (KMTS) Investor Outlook: Exploring a Promising 8.65% Upside in the Healthcare Sector

Kestra Medical Technologies, Ltd. (KMTS), a pioneering company in the healthcare sector, is capturing investor attention with its innovative wearable medical devices and digital healthcare solutions. Based in Kirkland, Washington,..

Scholar Rock Holding Corporation (SRRK) Stock Analysis: A Biotech Innovator with Strong Buy Ratings and 7.12% Upside Potential

Scholar Rock Holding Corporation (NASDAQ: SRRK) is capturing investor attention as a promising player in the biotechnology sector, offering innovative treatments for serious diseases. Despite a challenging financial landscape, the..

LifeStance Health Group, Inc. (LFST) Stock Analysis: Exploring a 26.94% Potential Upside in the Healthcare Sector

LifeStance Health Group, Inc. (NASDAQ: LFST), a prominent player in the healthcare sector, specifically in medical care facilities, has been making waves with its comprehensive approach to mental health services...

AtriCure, Inc. (ATRC) Stock Analysis: Exploring the 55.32% Potential Upside and Analysts’ Strong Buy Ratings

AtriCure, Inc. (NASDAQ: ATRC) stands out in the healthcare sector, particularly within the medical instruments and supplies industry. With a market capitalization of $1.58 billion, AtriCure focuses on innovative solutions..

Harrow, Inc. (HROW) Investor Outlook: A Potential 37% Upside in the Eyecare Pharmaceuticals Sector

Harrow, Inc. (HROW), a prominent player in the eyecare pharmaceutical industry, is drawing significant attention from investors, particularly given its promising potential upside of 37%. This Nashville-based company, which recently..

10x Genomics, Inc. (TXG) Stock Analysis: Navigating Growth Potential in Health Information Services

10x Genomics, Inc. (NASDAQ: TXG) stands as a prominent player in the healthcare sector, particularly within the health information services industry. With a market capitalization of $2.41 billion, the company..

Neogen Corporation (NEOG) Stock Analysis: Evaluating Its 5.20% Potential Upside in the Diagnostics & Research Sector

Neogen Corporation (NASDAQ: NEOG), a key player in the healthcare sector specializing in diagnostics and research, has been attracting investor attention due to its recent stock performance and growth potential...

Mineralys Therapeutics, Inc. (MLYS) Stock Analysis: A Biotech Gem with 77% Upside Potential

Mineralys Therapeutics, Inc. (NASDAQ: MLYS) is capturing the attention of investors with its compelling potential for growth in the biotechnology sector. With a market capitalization of $2.29 billion, this clinical-stage..

Establishment Labs Holdings Inc (ESTA) Stock Analysis: Healthcare Innovator with 11% Upside Potential

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a prominent player in the medical devices sector, has captured investor attention with its innovative approach to aesthetic and reconstructive plastic surgeries. Headquartered in..

Astrana Health Inc. (ASTH) Stock Analysis: A Healthcare Gem with Nearly 80% Upside Potential

Astrana Health Inc. (NASDAQ: ASTH) stands out in the healthcare sector with a compelling investment narrative, driven by its robust revenue growth and promising analyst ratings. As a medical care..

Edgewise Therapeutics, Inc. (EWTX) Stock Analysis: Target Price Suggests 26.84% Upside for Biotech Innovator

Edgewise Therapeutics, Inc. (NASDAQ: EWTX), a burgeoning player in the biotechnology sector, is attracting significant interest from investors, largely due to its promising pipeline of therapies aimed at tackling muscle..

Harmony Biosciences Holdings (HRMY) Stock Analysis: Positioned for a 70% Upside in Biotech Sector

Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) is making waves in the biotech industry with its focus on innovative therapies for neurological diseases. Investors seeking promising opportunities in the healthcare sector..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds